HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. grew its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,900 shares of the company's stock after buying an additional 1,500 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in HCA Healthcare were worth $23,682,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. First Horizon Advisors Inc. boosted its position in shares of HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company's stock valued at $623,000 after purchasing an additional 36 shares during the period. Mediolanum International Funds Ltd increased its holdings in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after acquiring an additional 36 shares during the period. Hartford Funds Management Co LLC grew its position in HCA Healthcare by 1.6% during the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company's stock worth $1,003,000 after purchasing an additional 39 shares during the last quarter. Prairie Wealth Advisors Inc. boosted its stake in shares of HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after buying an additional 40 shares during the period. Finally, Financial Counselors Inc. raised its stake in HCA Healthcare by 3.0% during the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company's stock valued at $630,000 after acquiring an additional 45 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. Raymond James cut HCA Healthcare from an "outperform" rating to a "market perform" rating in a research note on Friday, November 22nd. Barclays lowered their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Finally, Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

HCA Healthcare Price Performance

HCA stock traded up $4.81 on Monday, reaching $311.11. The company had a trading volume of 1,408,429 shares, compared to its average volume of 1,731,760. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company's fifty day moving average is $315.15 and its 200 day moving average is $349.23. The company has a market cap of $77.26 billion, a P/E ratio of 14.16, a PEG ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business posted $5.90 earnings per share. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.93%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.